FierceBiotech
  • FierceBiotech
  • FierceBiotechIT
  • FierceBiotechResearch
  • FierceBiomarkers
  • FierceDrugDelivery
  • FierceMedicalDevices
  • FierceVaccines
  • FiercePharma
  • FiercePharmaManufacturing
  • FierceCRO
  • More Fierce Network sites
  • Select another site
  • Advertise
  • Contact

Free Daily Biotech Industry Newsletter Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 100,000 biotech professionals who subscribe to FierceBiotech for FREE! Click here to see a sample.

FierceBiotech

  • News
  • TOPICS
    • Biosimilars
    • Chutes and Ladders
    • Clinical Trials
    • Drug Safety
    • Emerging Markets
    • Europe
    • M&A
    • Outsourcing
    • Partnering
    • Personalized Medicine
    • Pipeline
    • R&D
    • Regulatory
  • ANALYSIS
    • Third Rock's Levin calls for teamwork in personalized medicine
      by Damian Garde
    • Readers' picks, responses to Fierce's 'Top 10' cancer drugs report
      by Ryan McBride
    • More commentary
  • FEATURES
    • The Biggest R&D Spenders in Biotech
    • The Biggest R&D Spenders In Biopharma
    • Top 10 Late-Stage Cancer Drugs – 2012
  • LIBRARY
    • Webinars
    • View All
  • EVENTS
  • JOBS
    • Browse Jobs
    • Post a Job
  • Marketplace
  • Susbscribe
  • Twitter
  • Mobile
Follow US
Tag:

alnylam

Latest Headlines

Latest Headlines

Related Tags

  • RNAi
  • public offering
  • Tekmira
  • siRNA

alnylam Press Releases

  • Alnylam Initiates Phase I Clinical Study of ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin
  • Alnylam Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
  • Alnylam Pharmaceuticals Prices Public Offering of Common Stock
  • Alnylam Pharmaceuticals Announces Proposed Public Offering of Common Stock
  • Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2011 Financial Results

Join 100,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

  • MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
  • Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
  • What's your BIO?June 18-21, 2012 — Boston, MA
MORE EVENTS

Press Releases

  • Chronic Pain Is Relieved by Cell Transplantation in Lab Study
  • Drug-vaccine combo better for breast cancer
  • Marked for destruction: Newly developed compound triggers cancer cell death
  • Orthofix International Completes Divestiture of Sports Medicine Business Unit
  • ConforMIS iTotal CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards
  • More Press Releases

Featured Jobs

  • Food Development Scientist Job
    Yoh - Park Ridge, NJ, USA
  • Scientist II Job
    Yoh - Niskayuna, NY, USA
  • Senior Manager, Clinical Data Management
    TESARO - Waltham, MA
  • Senior Manager, API Development
    TESARO - Waltham, MA
  • Pilot Manufacturing Scientist Job
    Yoh - Cambridge, MA, USA

A publication of FierceMarkets

FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 100,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom
  • FierceWireless
  • FierceBroadbandWireless
  • FierceMobileContent
  • FierceDeveloper
  • FierceWireless:Europe
  • FierceTelecom
  • FierceEnterpriseCommunications
  • FierceIPTV
  • FierceOnlineVideo
  • FierceCable
Healthcare
  • FierceHealthcare
  • FiercePracticeManagement
  • FierceHealthIT
  • FierceHealthFinance
  • Hospital Impact
  • FierceEMR
  • FierceMobileHealthcare
  • FierceHealthPayer
Government
  • FierceGovernment
  • FierceGovernmentIT
  • FierceHomelandSecurity
Energy
  • FierceEnergy
  • FierceSmartGrid
Life Sciences
  • FierceBiotech
  • FierceBiotechResearch
  • FiercePharma
  • FierceVaccines
  • FierceBiotechIT
  • FiercePharmaManufacturing
  • FierceMedicalDevices
  • FierceDrugDelivery
  • FierceBiomarkers
  • FierceCRO
Enterprise IT
  • FierceCIO
  • FierceCIO:TechWatch
  • FierceMobileIT
  • FierceContentManagement
Finance
  • FierceFinance
  • FierceComplianceIT
  • FierceFinanceIT
  • Home
  • Subscribe
  • Advertise
  • Mobile Edition
  • RSS
  • Privacy
  • Editors
© 2012 FierceMarkets. All rights reserved.